2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$7.08+$0.29 (+4.20%)
Price as of Aug 03, 2026 10:19 AM EDT- $263.6MMarket Cap
- 17.07%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$7.08+$0.29 (+4.20%)
TRDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.79 | ||
Change | +$0.02 (+0.30%) | ||
Open | $6.71 | ||
High | $6.90 | ||
Low | $6.49 | ||
Previous Close | $6.77 | ||
Volume | 352,598 | ||
30-Day Average Volume | 436,200 | ||
1-Week Change | 16.07% | ||
1-Month Change | -7.74% | ||
1-Year Change | 17.07% | ||
3-Year Change | -60.91% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.8M | ||
Total Assets | $335.5M | ||
Market Cap | $263.6M | ||
Enterprise Value | $187.1M | ||
Period: QTR TTM FY | |||
Revenue | $875,000.00 | ||
Net Income | -$39.7M | ||
Free Cash Flow | -$41.7M | ||
EBIT | -$39.7M | ||
EBITDA | -$38.9M | ||
Net Working Capital | $247.7M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 214 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 8 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue